Skip to main content
Indegene Limited logo

Indegene Limited — Investor Relations & Filings

Ticker · INDGN ISIN · INE065X01017 LEI · 335800XFEREFIW9LG995 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 290 across all filing types
Latest filing 2026-01-30 Regulatory Filings
Country IN India
Listing BSE.NS INDGN

About Indegene Limited

https://www.indegene.com/

Indegene Limited provides digital-led commercialization services for the life sciences sector. The company integrates deep domain knowledge with proprietary technology platforms to assist biopharmaceutical, emerging biotech, and medical device organizations. Its core offerings span the entire product lifecycle, including clinical development support, regulatory compliance, pharmacovigilance, and multi-channel marketing operations. By leveraging artificial intelligence and machine learning, Indegene enables clients to optimize drug development processes, enhance patient engagement, and drive operational efficiencies. The company focuses on modernizing traditional commercial models through data-driven insights and digital transformation strategies, helping global healthcare organizations navigate complex regulatory environments and improve health outcomes through scaled, technology-enabled solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter dated January 30, 2026, addressed to stock exchanges regarding the audio recording of the Q3FY26 earnings call. It provides a link to the audio recording and states that the information will be available on the company's website. The document does not contain the transcript or detailed financial data but is an announcement about the availability of the earnings call recording. Given the short length (1467 characters) and the nature of the content, this is not the earnings release itself nor a full call transcript but an announcement related to the earnings call. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call recording availability.
2026-01-30 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the opening of the trading window for insiders to trade the company's securities. It references the SEBI regulations and the company's code of conduct related to insider trading. The document mentions the upcoming approval and declaration of financial results for the quarter ended December 31, 2025, but does not contain any financial data or results itself. It is essentially an announcement related to trading compliance and timing, not a financial report or earnings release. Given the short length (1593 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-29 English
Allotment of Securities
Regulatory Filings
2026-01-29 English
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended December 31, 2025' and is issued pursuant to SEBI regulations related to the monitoring of IPO proceeds. It contains detailed information about the utilization of IPO funds, deviations from the objects of the issue, and certifications by the monitoring agency. The report includes financial data on the use of proceeds, progress on the objects funded by the IPO, and compliance with regulatory requirements. The document is substantive, over 15,000 characters, and contains actual financial and operational data related to the quarter ended December 31, 2025. This fits the definition of a regulatory compliance report related to capital raising but is not a full annual or interim financial report. It is a standalone monitoring agency report required by SEBI for IPO proceeds utilization. Therefore, the most appropriate classification is 'Regulatory Filings (RNS)' as it is a regulatory compliance document that does not fit into other specific financial report categories like Annual Report or Interim Report.
2026-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Interim / Quarterly Report Classification · 95% confidence The document is an analyst presentation and fact sheet for the quarter ended December 31, 2025, as stated in the opening paragraph. It includes detailed management commentary, financial highlights, segment performance, business highlights, and strategic growth approaches. The content is comprehensive and focused on quarterly financial results and operational updates, including revenue, EBITDA, and acquisitions. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and management discussion aligns with the characteristics of an Interim / Quarterly Report (IR). It is not a brief earnings release (ER) since it contains extensive analysis and segment data, nor is it a full annual report (10-K). Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-01-29 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated January 29, 2026, announcing Indegene Limited's financial results for the quarter ended December 31, 2025 (Q3 FY26). It includes key financial highlights such as revenue, EBITDA, profit after tax, and growth percentages. The document is titled 'Press Release' and contains detailed quarterly financial performance data, including YoY and QoQ growth, which is typical of an Earnings Release. It is not a full quarterly report with comprehensive financial statements or management discussion, but rather an initial announcement of quarterly financial results. Therefore, the document fits the definition of an Earnings Release (ER). The document length is 5698 characters, which is consistent with a press release rather than a full interim report. Hence, the classification is ER with high confidence.
2026-01-29 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.